熱門資訊> 正文
Applied DNA Sciences重新获得纳斯达克合规性
2025-07-07 21:19
- Applied DNA Sciences (NASDAQ:APDN) announced on Monday that it received a Nasdaq notice informing that the company has regained compliance with Nasdaq's minimum bid price requirement rule of $1.00 per share for continued listing.
- Nasdaq also notified the company in the compliance notice that the hearing before the Nasdaq Hearings Panel previously scheduled to take place on July 15, 2025, has been cancelled, and the company's securities will continue to be listed and traded on Nasdaq.
- APDN +1.07% premarket to $4.68.
- Source: Press Release
More on Applied DNA Sciences
- Applied DNA Sciences to focus solely on synthetic DNA, cuts 27% of staff
- Applied DNA Chairperson and CEO James A. Hayward resigns
- Seeking Alpha’s Quant Rating on Applied DNA Sciences
- Historical earnings data for Applied DNA Sciences
- Financial information for Applied DNA Sciences
推薦文章
一周財經日曆 | 事關降息！中美5月CPI、PPI重磅出爐！新股「超購王」大行科工下周上市
高盛：降新鴻基地產目標價至96港元 評級「買入」
特朗普白宮宴請硅谷巨頭 各大公司CEO紛紛重申在美投資承諾
非農前糟糕就業數據引爆降息預期 10年期美債收益率創四個月新低
AI收入超預期！芯片巨頭博通交出滿分財報 神祕百億訂單帶來驚喜
華盛早報 | 特朗普突然宣佈！對未進入美國市場的芯片公司加徵關税；瑞銀稱中國AI變現取得進展
Lululemon Athletica連續第二次下調全年業績指引 盤后股價一度暴跌超15%
9月5日外盤頭條：馬斯克回絕白宮科技CEO晚宴邀請 波音罷工持續無奈招募替代工人 露露檸檬股價盤后暴跌10%
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
